AU2003251286B2
(en)
*
|
2002-01-23 |
2007-08-16 |
The University Of Utah Research Foundation |
Targeted chromosomal mutagenesis using zinc finger nucleases
|
WO2003080809A2
(en)
|
2002-03-21 |
2003-10-02 |
Sangamo Biosciences, Inc. |
Methods and compositions for using zinc finger endonucleases to enhance homologous recombination
|
US9447434B2
(en)
|
2002-09-05 |
2016-09-20 |
California Institute Of Technology |
Use of chimeric nucleases to stimulate gene targeting
|
US8409861B2
(en)
|
2003-08-08 |
2013-04-02 |
Sangamo Biosciences, Inc. |
Targeted deletion of cellular DNA sequences
|
US7888121B2
(en)
*
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
US20120196370A1
(en)
|
2010-12-03 |
2012-08-02 |
Fyodor Urnov |
Methods and compositions for targeted genomic deletion
|
EP2927318B1
(de)
*
|
2003-08-08 |
2020-05-20 |
Sangamo Therapeutics, Inc. |
Verfahren und Zusammensetzungen für gezielte Spaltung und Rekombination
|
US11311574B2
(en)
|
2003-08-08 |
2022-04-26 |
Sangamo Therapeutics, Inc. |
Methods and compositions for targeted cleavage and recombination
|
WO2005028630A2
(en)
|
2003-09-19 |
2005-03-31 |
Sangamo Biosciences, Inc. |
Engineered zinc finger proteins for regulation of gene expression
|
US7972854B2
(en)
|
2004-02-05 |
2011-07-05 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
US20080131962A1
(en)
|
2006-05-25 |
2008-06-05 |
Sangamo Biosciences, Inc. |
Engineered cleavage half-domains
|
CA2579677A1
(en)
|
2004-09-16 |
2006-03-30 |
Sangamo Biosciences, Inc. |
Compositions and methods for protein production
|
KR101419729B1
(ko)
*
|
2005-07-26 |
2014-07-17 |
상가모 바이오사이언스 인코포레이티드 |
외래 핵산 서열의 표적화된 통합 및 발현
|
AU2012245168B2
(en)
*
|
2005-07-26 |
2014-12-11 |
Sangamo Therapeutics, Inc. |
Targeted Integration and Expression of Exogenous Nucleic Acid Sequences
|
DK2650365T3
(en)
|
2005-10-18 |
2016-12-05 |
Prec Biosciences |
RATIONAL MEGANUCLEASES constructed with altered sequence specificity and DNA binding affinity
|
US20070154989A1
(en)
*
|
2006-01-03 |
2007-07-05 |
The Scripps Research Institute |
Zinc finger domains specifically binding agc
|
WO2007134272A2
(en)
*
|
2006-05-12 |
2007-11-22 |
Janssen Pharmaceutica N.V. |
Humanized models via targeted mtagenesis with zinc finger nuclease
|
JP2009537140A
(ja)
*
|
2006-05-19 |
2009-10-29 |
サンガモ バイオサイエンシーズ, インコーポレイテッド |
ジヒドロ葉酸還元酵素の不活性化のための方法及び組成物
|
WO2007139982A2
(en)
*
|
2006-05-25 |
2007-12-06 |
Sangamo Biosciences, Inc. |
Methods and compositions for gene inactivation
|
AU2007284748B2
(en)
|
2006-08-11 |
2013-05-16 |
Corteva Agriscience Llc |
Zinc finger nuclease-mediated homologous recombination
|
CA2667414C
(en)
*
|
2006-11-13 |
2015-12-29 |
Sangamo Biosciences, Inc. |
Methods and compositions for modification of the human glucocorticoid receptor locus
|
PT2415873E
(pt)
|
2006-12-14 |
2015-03-31 |
Sangamo Biosciences Inc |
Proteínas com dedos de zinco não canónicas optimizadas
|
US8748146B2
(en)
*
|
2007-04-19 |
2014-06-10 |
Celexion, Llc |
Engineered nucleases and their uses for nucleic acid assembly
|
CA2684378C
(en)
|
2007-04-26 |
2016-11-29 |
Sangamo Biosciences, Inc. |
Targeted integration into the ppp1r12c locus
|
AU2008262487B2
(en)
*
|
2007-05-23 |
2013-10-31 |
Sangamo Therapeutics, Inc. |
Methods and compositions for increased transgene expression
|
EP2568048A1
(de)
|
2007-06-29 |
2013-03-13 |
Pioneer Hi-Bred International, Inc. |
Verfahren zur Veränderung des Genoms einer Zelle von Einkeimblättrigen
|
CN101883850B
(zh)
*
|
2007-07-12 |
2014-11-12 |
桑格摩生物科学股份有限公司 |
用于失活α-1,6岩藻糖基转移酶(FUT8)基因表达的方法和组合物
|
CN101878307B
(zh)
*
|
2007-09-27 |
2017-07-28 |
陶氏益农公司 |
以5‑烯醇式丙酮酰莽草酸‑3‑磷酸合酶基因为靶的改造锌指蛋白
|
WO2009042186A2
(en)
*
|
2007-09-27 |
2009-04-02 |
Sangamo Biosciences, Inc. |
Genomic editing in zebrafish using zinc finger nucleases
|
EP2188384B1
(de)
*
|
2007-09-27 |
2015-07-15 |
Sangamo BioSciences, Inc. |
Schnelle in-vivo-identifizierung von biologisch aktiven nukleasen
|
US11235026B2
(en)
|
2007-09-27 |
2022-02-01 |
Sangamo Therapeutics, Inc. |
Methods and compositions for modulating PD1
|
US8563314B2
(en)
|
2007-09-27 |
2013-10-22 |
Sangamo Biosciences, Inc. |
Methods and compositions for modulating PD1
|
US20110014616A1
(en)
*
|
2009-06-30 |
2011-01-20 |
Sangamo Biosciences, Inc. |
Rapid screening of biologically active nucleases and isolation of nuclease-modified cells
|
JP2011500082A
(ja)
|
2007-10-25 |
2011-01-06 |
サンガモ バイオサイエンシーズ, インコーポレイテッド |
標的組込みのための方法および組成物
|
CA2703079A1
(en)
*
|
2007-12-07 |
2009-06-18 |
Precision Biosciences, Inc. |
Rationally-designed meganucleases with recognition sequences found in dnase hypersensitive regions of the human genome
|
WO2009114321A2
(en)
|
2008-03-11 |
2009-09-17 |
Precision Biosciencs, Inc. |
Rationally-designed meganucleases for maize genome engineering
|
US20100071083A1
(en)
*
|
2008-03-12 |
2010-03-18 |
Smith James J |
Temperature-dependent meganuclease activity
|
CA2720903C
(en)
|
2008-04-14 |
2019-01-15 |
Sangamo Biosciences, Inc. |
Linear donor constructs for targeted integration
|
WO2009146179A1
(en)
|
2008-04-15 |
2009-12-03 |
University Of Iowa Research Foundation |
Zinc finger nuclease for the cftr gene and methods of use thereof
|
JP2011519558A
(ja)
*
|
2008-04-28 |
2011-07-14 |
プレシジョン バイオサイエンシズ,インク. |
合理的に設計されたdna結合タンパク質とエフェクタードメインとの融合分子
|
ES2625941T3
(es)
|
2008-07-14 |
2017-07-21 |
Precision Biosciences, Inc. |
Secuencias de reconocimiento para meganucleasas derivadas de i-crei y sus usos
|
KR20160015400A
(ko)
|
2008-08-22 |
2016-02-12 |
상가모 바이오사이언스 인코포레이티드 |
표적화된 단일가닥 분할 및 표적화된 통합을 위한 방법 및 조성물
|
EP2180058A1
(de)
*
|
2008-10-23 |
2010-04-28 |
Cellectis |
Meganuklease-Rekombinationssystem
|
CA2741119C
(en)
*
|
2008-10-29 |
2019-02-12 |
Sangamo Biosciences, Inc. |
Methods and compositions for inactivating glutamine synthetase gene expression
|
US20110023148A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genome editing of addiction-related genes in animals
|
US20110016546A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Porcine genome editing with zinc finger nucleases
|
US20110023139A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in cardiovascular disease
|
US20110023146A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in secretase-associated disorders
|
US20110016539A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Genome editing of neurotransmission-related genes in animals
|
US20110016543A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in inflammation
|
CA2745031C
(en)
*
|
2008-12-04 |
2018-08-14 |
Sangamo Biosciences, Inc. |
Genome editing in rats using zinc-finger nucleases
|
US20110023140A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Rabbit genome editing with zinc finger nucleases
|
US20110023156A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Feline genome editing with zinc finger nucleases
|
US20110023145A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in autism spectrum disorders
|
US20110023151A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genome editing of abc transporters
|
US20110023154A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Silkworm genome editing with zinc finger nucleases
|
US20110023153A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in alzheimer's disease
|
US20110016542A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Canine genome editing with zinc finger nucleases
|
US20110023147A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of prion disorder-related genes in animals
|
US20110023149A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in tumor suppression in animals
|
US20110023141A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved with parkinson's disease
|
US20110016540A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Genome editing of genes associated with trinucleotide repeat expansion disorders in animals
|
US20110016541A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Genome editing of sensory-related genes in animals
|
US20110023152A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genome editing of cognition related genes in animals
|
US20110023143A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of neurodevelopmental genes in animals
|
US20110030072A1
(en)
*
|
2008-12-04 |
2011-02-03 |
Sigma-Aldrich Co. |
Genome editing of immunodeficiency genes in animals
|
US20110023159A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Ovine genome editing with zinc finger nucleases
|
US20110023157A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Equine genome editing with zinc finger nucleases
|
US20110023150A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genome editing of genes associated with schizophrenia in animals
|
US20110023144A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in amyotrophyic lateral sclerosis disease
|
US20110023158A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Bovine genome editing with zinc finger nucleases
|
US8329986B2
(en)
*
|
2008-12-17 |
2012-12-11 |
Dow Agrosciences, Llc |
Targeted integration into the Zp15 locus
|
EP2408921B1
(de)
|
2009-03-20 |
2017-04-19 |
Sangamo BioSciences, Inc. |
Modifikation von cxcr4 mit manipulierten zink-fingerproteinen
|
EP2419511B1
(de)
|
2009-04-09 |
2018-01-17 |
Sangamo Therapeutics, Inc. |
Gezielte integration in stammzellen
|
US8772008B2
(en)
*
|
2009-05-18 |
2014-07-08 |
Sangamo Biosciences, Inc. |
Methods and compositions for increasing nuclease activity
|
US20120171771A1
(en)
|
2009-07-08 |
2012-07-05 |
Cellular Dynamics International, Inc. |
Modified ips cells having a mutant form of a human immunodeficiency virus (hiv) cellular entry gene
|
CN102858985A
(zh)
*
|
2009-07-24 |
2013-01-02 |
西格马-奥尔德里奇有限责任公司 |
基因组编辑方法
|
WO2011011767A1
(en)
*
|
2009-07-24 |
2011-01-27 |
Sigma-Aldrich Co. |
Method for genome editing
|
EP2461819A4
(de)
|
2009-07-28 |
2013-07-31 |
Sangamo Biosciences Inc |
Verfahren und zusammensetzungen zur behandlung erblicher trinukleotiderkrankungen
|
BR112012003257A2
(pt)
*
|
2009-08-11 |
2016-11-22 |
Sangamo Biosciences Inc |
organismos homozigotos para modificação direcionada
|
EP2493288B1
(de)
*
|
2009-10-28 |
2015-02-18 |
Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
Homologe rekombination in der eizelle
|
US8956828B2
(en)
|
2009-11-10 |
2015-02-17 |
Sangamo Biosciences, Inc. |
Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
|
WO2011078662A1
(en)
*
|
2009-12-21 |
2011-06-30 |
Keygene N.V. |
Dsrna for improved genetic modification of plant dna
|
GEP20176628B
(en)
|
2010-01-22 |
2017-02-27 |
Sangamo Biosciences Inc |
Targeted genomic alteration
|
US9695432B2
(en)
*
|
2010-01-22 |
2017-07-04 |
Dow Agrosciences Llc |
Excision of transgenes in genetically modified organisms
|
WO2011091324A2
(en)
*
|
2010-01-22 |
2011-07-28 |
The Scripps Research Institute |
Methods of generating zinc finger nucleases having altered activity
|
JP6137596B2
(ja)
|
2010-02-08 |
2017-05-31 |
サンガモ セラピューティクス, インコーポレイテッド |
遺伝子操作された切断ハーフドメイン
|
US9255259B2
(en)
*
|
2010-02-09 |
2016-02-09 |
Sangamo Biosciences, Inc. |
Targeted genomic modification with partially single-stranded donor molecules
|
CN102939377B
(zh)
|
2010-04-26 |
2016-06-08 |
桑格摩生物科学股份有限公司 |
使用锌指核酸酶对Rosa位点进行基因组编辑
|
CN103025344B
(zh)
|
2010-05-17 |
2016-06-29 |
桑格摩生物科学股份有限公司 |
新型dna-结合蛋白及其用途
|
US8945868B2
(en)
|
2010-07-21 |
2015-02-03 |
Sangamo Biosciences, Inc. |
Methods and compositions for modification of a HLA locus
|
KR20180121665A
(ko)
*
|
2010-07-23 |
2018-11-07 |
시그마-알드리치 컴퍼니., 엘엘씨 |
표적화 엔도뉴클레아제 및 단일-가닥 핵산을 사용하는 게놈 편집
|
WO2012018726A1
(en)
*
|
2010-08-02 |
2012-02-09 |
Cellectis Sa |
Method for increasing double-strand break-induced gene targeting
|
EP3511420B1
(de)
|
2010-09-27 |
2021-04-07 |
Sangamo Therapeutics, Inc. |
Zusammensetzungen zur hemmung des eindringens von viren in zellen
|
AU2011316575B2
(en)
|
2010-10-12 |
2015-10-29 |
Sangamo Therapeutics, Inc. |
Methods and compositions for treating hemophilia B
|
US9121059B2
(en)
|
2010-12-22 |
2015-09-01 |
Genia Technologies, Inc. |
Nanopore-based single molecule characterization
|
US9267123B2
(en)
|
2011-01-05 |
2016-02-23 |
Sangamo Biosciences, Inc. |
Methods and compositions for gene correction
|
CN102174649B
(zh)
*
|
2011-01-18 |
2013-06-12 |
陕西师范大学 |
快速检测锌指核酸酶介导基因定点整合的方法
|
US10920242B2
(en)
|
2011-02-25 |
2021-02-16 |
Recombinetics, Inc. |
Non-meiotic allele introgression
|
US9528124B2
(en)
|
2013-08-27 |
2016-12-27 |
Recombinetics, Inc. |
Efficient non-meiotic allele introgression
|
CN102206631A
(zh)
*
|
2011-03-08 |
2011-10-05 |
西北农林科技大学 |
一种开源方式筛选靶向结合人dyrk1a基因靶位点的锌指蛋白的方法
|
CN102358902B
(zh)
*
|
2011-04-02 |
2013-01-02 |
西南大学 |
家蚕丝素重链基因突变序列及突变的方法和应用
|
WO2012152912A1
(en)
|
2011-05-12 |
2012-11-15 |
Newvectys |
Genetically modified pig as a cancer prone model
|
WO2012169916A2
(en)
|
2011-06-08 |
2012-12-13 |
Międzynarodowy Instytut Biologii Molekularnej I Komórkowej |
Sequence-specific engineered ribonuclease h and the method for determining the sequence preference of dna-rna hybrid binding proteins
|
CA2841541C
(en)
|
2011-07-25 |
2019-11-12 |
Sangamo Biosciences, Inc. |
Methods and compositions for alteration of a cystic fibrosis transmembrane conductance regulator (cftr) gene
|
CN103917644A
(zh)
|
2011-09-21 |
2014-07-09 |
桑格摩生物科学股份有限公司 |
调控转基因表达的方法和组合物
|
AU2012328682B2
(en)
|
2011-10-27 |
2017-09-21 |
Sangamo Therapeutics, Inc. |
Methods and compositions for modification of the HPRT locus
|
EP2780460B1
(de)
|
2011-11-16 |
2018-07-11 |
Sangamo Therapeutics, Inc. |
Modifizierte dna-bindende proteine und verwendungen davon
|
GB201122458D0
(en)
|
2011-12-30 |
2012-02-08 |
Univ Wageningen |
Modified cascade ribonucleoproteins and uses thereof
|
WO2013130824A1
(en)
|
2012-02-29 |
2013-09-06 |
Sangamo Biosciences, Inc. |
Methods and compositions for treating huntington's disease
|
CN104364380B
(zh)
|
2012-04-25 |
2018-10-09 |
瑞泽恩制药公司 |
核酸酶介导的使用大靶向载体的靶向
|
UA115875C2
(uk)
*
|
2012-05-02 |
2018-01-10 |
ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі |
Рослина помідора зі зменшеною активністю малатдегідрогенази та спосіб її отримання
|
AU2013259647B2
(en)
|
2012-05-07 |
2018-11-08 |
Corteva Agriscience Llc |
Methods and compositions for nuclease-mediated targeted integration of transgenes
|
JP6343605B2
(ja)
|
2012-05-25 |
2018-06-13 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
Rna依存性標的dna修飾およびrna依存性転写調節のための方法および組成物
|
JP2015525077A
(ja)
|
2012-06-15 |
2015-09-03 |
ジェニア・テクノロジーズ・インコーポレイテッド |
チップの構成および高精度な核酸配列決定
|
EP2861737B1
(de)
|
2012-06-19 |
2019-04-17 |
Regents Of The University Of Minnesota |
Gen-targeting in pflanzen durch dns-viren
|
DK2872625T3
(en)
*
|
2012-07-11 |
2017-02-06 |
Sangamo Biosciences Inc |
METHODS AND COMPOSITIONS FOR TREATING LYSOSOMAL STORAGE DISEASES
|
US10648001B2
(en)
|
2012-07-11 |
2020-05-12 |
Sangamo Therapeutics, Inc. |
Method of treating mucopolysaccharidosis type I or II
|
JP6329537B2
(ja)
|
2012-07-11 |
2018-05-23 |
サンガモ セラピューティクス, インコーポレイテッド |
生物学的薬剤の送達のための方法および組成物
|
US10058078B2
(en)
|
2012-07-31 |
2018-08-28 |
Recombinetics, Inc. |
Production of FMDV-resistant livestock by allele substitution
|
SI2890780T1
(sl)
|
2012-08-29 |
2020-11-30 |
Sangamo Therapeutics, Inc. |
Postopki in sestavki za zdravljenje genetskega stanja
|
UA118090C2
(uk)
|
2012-09-07 |
2018-11-26 |
ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі |
Спосіб інтегрування послідовності нуклеїнової кислоти, що представляє інтерес, у ген fad2 у клітині сої та специфічний для локусу fad2 білок, що зв'язується, здатний індукувати спрямований розрив
|
AU2013312538B2
(en)
|
2012-09-07 |
2019-01-24 |
Corteva Agriscience Llc |
FAD3 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks
|
UA119135C2
(uk)
|
2012-09-07 |
2019-05-10 |
ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі |
Спосіб отримання трансгенної рослини
|
EP2906684B8
(de)
|
2012-10-10 |
2020-09-02 |
Sangamo Therapeutics, Inc. |
T-zell-modifizierende verbindungen und verwendungen davon
|
US9605309B2
(en)
|
2012-11-09 |
2017-03-28 |
Genia Technologies, Inc. |
Nucleic acid sequencing using tags
|
CN103215234B
(zh)
*
|
2012-11-09 |
2014-12-10 |
陕西师范大学 |
携带锌指核酸酶表达元件和供体dna的腺病毒及其构建方法和应用
|
JP2016500254A
(ja)
|
2012-12-05 |
2016-01-12 |
サンガモ バイオサイエンシーズ, インコーポレイテッド |
代謝疾患の調節のための方法および組成物
|
ES2769310T3
(es)
*
|
2012-12-06 |
2020-06-25 |
Sigma Aldrich Co Llc |
Modificación y regulación del genoma basada en CRISPR
|
WO2014093768A1
(en)
*
|
2012-12-13 |
2014-06-19 |
Ainley W Michael |
Precision gene targeting to a particular locus in maize
|
US10030063B2
(en)
|
2012-12-18 |
2018-07-24 |
Novartis Ag |
Production of therapeutic proteins in genetically modified mammalian cells
|
WO2014104878A1
(en)
*
|
2012-12-27 |
2014-07-03 |
Keygene N.V. |
Method for removing genetic linkage in a plant
|
SG10201706741VA
(en)
|
2013-02-20 |
2017-10-30 |
Regeneron Pharma |
Genetic modification of rats
|
US10227610B2
(en)
|
2013-02-25 |
2019-03-12 |
Sangamo Therapeutics, Inc. |
Methods and compositions for enhancing nuclease-mediated gene disruption
|
US10329574B2
(en)
|
2013-03-12 |
2019-06-25 |
E I Du Pont De Nemours And Company |
Methods for the identification of variant recognition sites for rare-cutting engineered double-strand-break-inducing agents and compositions and uses thereof
|
WO2014152832A1
(en)
|
2013-03-14 |
2014-09-25 |
Immusoft Corporation |
Methods for in vitro memory b cell differentiation and transduction with vsv-g pseudotyped viral vectors
|
CA2905432C
(en)
|
2013-03-14 |
2021-09-14 |
Caribou Biosciences, Inc. |
Compositions and methods of nucleic acid-targeting nucleic acids
|
CN105208866B
(zh)
|
2013-03-21 |
2018-11-23 |
桑格摩生物治疗股份有限公司 |
使用工程化锌指蛋白核酸酶靶向断裂t细胞受体基因
|
WO2014165612A2
(en)
|
2013-04-05 |
2014-10-09 |
Dow Agrosciences Llc |
Methods and compositions for integration of an exogenous sequence within the genome of plants
|
PT3456831T
(pt)
|
2013-04-16 |
2021-09-10 |
Regeneron Pharma |
Modificação alvejada do genoma de rato
|
US10604771B2
(en)
*
|
2013-05-10 |
2020-03-31 |
Sangamo Therapeutics, Inc. |
Delivery methods and compositions for nuclease-mediated genome engineering
|
CA2910489A1
(en)
|
2013-05-15 |
2014-11-20 |
Sangamo Biosciences, Inc. |
Methods and compositions for treatment of a genetic condition
|
CA2913404C
(en)
*
|
2013-06-14 |
2023-10-03 |
Cellectis |
Methods for non-transgenic genome editing in plants
|
US10563225B2
(en)
*
|
2013-07-26 |
2020-02-18 |
President And Fellows Of Harvard College |
Genome engineering
|
WO2015017866A1
(en)
|
2013-08-02 |
2015-02-05 |
Enevolv, Inc. |
Processes and host cells for genome, pathway, and biomolecular engineering
|
AU2014312295C1
(en)
|
2013-08-28 |
2020-08-13 |
Sangamo Therapeutics, Inc. |
Compositions for linking DNA-binding domains and cleavage domains
|
CN105682452B
(zh)
|
2013-09-04 |
2018-10-16 |
美国陶氏益农公司 |
用于在作物中确定供体插入的快速靶向分析
|
US9957526B2
(en)
|
2013-10-17 |
2018-05-01 |
Sangamo Therapeutics, Inc. |
Delivery methods and compositions for nuclease-mediated genome engineering
|
WO2015057976A1
(en)
|
2013-10-17 |
2015-04-23 |
Sangamo Biosciences, Inc. |
Delivery methods and compositions for nuclease-mediated genome engineering in hematopoietic stem cells
|
US9322062B2
(en)
|
2013-10-23 |
2016-04-26 |
Genia Technologies, Inc. |
Process for biosensor well formation
|
CN109797199A
(zh)
|
2013-10-23 |
2019-05-24 |
吉尼亚科技公司 |
使用纳米孔的高速分子感测
|
US10093940B2
(en)
|
2013-11-04 |
2018-10-09 |
Dow Agrosciences Llc |
Optimal maize loci
|
CA2926822C
(en)
|
2013-11-04 |
2022-12-13 |
Dow Agrosciences Llc |
Optimal soybean loci
|
US9909131B2
(en)
|
2013-11-04 |
2018-03-06 |
Dow Agrosciences Llc |
Optimal soybean loci
|
JP6633532B2
(ja)
|
2013-11-04 |
2020-01-22 |
ダウ アグロサイエンシィズ エルエルシー |
最適なトウモロコシ遺伝子座
|
NZ719477A
(en)
|
2013-11-11 |
2022-05-27 |
Sangamo Therapeutics Inc |
Methods and compositions for treating huntington’s disease
|
RS62559B1
(sr)
|
2013-11-13 |
2021-12-31 |
Childrens Medical Center |
Nukleazom posredovana regulacija eksprimiranja gena
|
US9951353B2
(en)
*
|
2013-11-15 |
2018-04-24 |
The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services |
Engineering neural stem cells using homologous recombination
|
WO2015089077A2
(en)
|
2013-12-09 |
2015-06-18 |
Sangamo Biosciences, Inc. |
Methods and compositions for genome engineering
|
KR102170502B1
(ko)
|
2013-12-11 |
2020-10-28 |
리제너론 파마슈티칼스 인코포레이티드 |
게놈의 표적화된 변형을 위한 방법 및 조성물
|
HUE041331T2
(hu)
|
2013-12-11 |
2019-05-28 |
Regeneron Pharma |
Módszerek és készítmények a genom célzott módosításához
|
US20160333063A1
(en)
|
2013-12-13 |
2016-11-17 |
The General Hospital Corporation |
Soluble high molecular weight (hmw) tau species and applications thereof
|
US10774338B2
(en)
|
2014-01-16 |
2020-09-15 |
The Regents Of The University Of California |
Generation of heritable chimeric plant traits
|
LT3102673T
(lt)
|
2014-02-03 |
2020-08-25 |
Sangamo Therapeutics, Inc. |
Beta talasemijos gydymo būdai ir kompozicijos
|
US10036034B2
(en)
*
|
2014-02-13 |
2018-07-31 |
Nutech Ventures |
Sequences involved in plant yield and methods of using
|
CN106232814B
(zh)
|
2014-02-13 |
2021-05-11 |
宝生物工程(美国)有限公司 |
从核酸的初始集合中耗尽靶分子的方法、以及用于实践其的组合物和试剂盒
|
WO2015125862A1
(ja)
*
|
2014-02-19 |
2015-08-27 |
国立研究開発法人 農業生物資源研究所 |
標的dnaに変異が導入された植物細胞、及びその製造方法
|
US10370680B2
(en)
|
2014-02-24 |
2019-08-06 |
Sangamo Therapeutics, Inc. |
Method of treating factor IX deficiency using nuclease-mediated targeted integration
|
WO2015129686A1
(ja)
|
2014-02-25 |
2015-09-03 |
国立研究開発法人 農業生物資源研究所 |
標的dnaに変異が導入された植物細胞、及びその製造方法
|
CA2947941C
(en)
|
2014-03-05 |
2021-02-23 |
National University Corporation Kobe University |
Genome sequence modification method for specifically converting nucleic acid bases of targeted dna sequence, and molecular complex for use in same
|
AU2015231353B2
(en)
|
2014-03-18 |
2020-11-05 |
Sangamo Therapeutics, Inc. |
Methods and compositions for regulation of zinc finger protein expression
|
US9522936B2
(en)
|
2014-04-24 |
2016-12-20 |
Sangamo Biosciences, Inc. |
Engineered transcription activator like effector (TALE) proteins
|
KR20170003585A
(ko)
|
2014-04-28 |
2017-01-09 |
리컴비네틱스 인코포레이티드 |
돼지에서 멀티플렉스 유전자 편집
|
KR102380324B1
(ko)
|
2014-05-08 |
2022-03-30 |
상가모 테라퓨틱스, 인코포레이티드 |
헌팅턴병을 치료하기 위한 방법 및 조성물
|
WO2015175642A2
(en)
|
2014-05-13 |
2015-11-19 |
Sangamo Biosciences, Inc. |
Methods and compositions for prevention or treatment of a disease
|
WO2015188056A1
(en)
|
2014-06-05 |
2015-12-10 |
Sangamo Biosciences, Inc. |
Methods and compositions for nuclease design
|
SG10201913804WA
(en)
|
2014-06-06 |
2020-03-30 |
Regeneron Pharma |
Methods and compositions for modifying a targeted locus
|
AU2014398050B2
(en)
*
|
2014-06-19 |
2018-05-24 |
Colgate-Palmolive Company |
Oral care implement
|
BR112016030145A8
(pt)
|
2014-06-23 |
2018-12-11 |
Regeneron Pharma |
métodos para a montagem de ao menos dois ácidos nucleicos e de dois ou mais ácidos nucleicos
|
EP3161128B1
(de)
|
2014-06-26 |
2018-09-26 |
Regeneron Pharmaceuticals, Inc. |
Verfahren und zusammensetzungen zur gezielten genetischen veränderung und verfahren zur verwendung
|
EP3166964A1
(de)
|
2014-07-08 |
2017-05-17 |
Vib Vzw |
Mittel und verfahren zur steigerung des pflanzenertrags
|
WO2016014794A1
(en)
|
2014-07-25 |
2016-01-28 |
Sangamo Biosciences, Inc. |
Methods and compositions for modulating nuclease-mediated genome engineering in hematopoietic stem cells
|
US9757420B2
(en)
|
2014-07-25 |
2017-09-12 |
Sangamo Therapeutics, Inc. |
Gene editing for HIV gene therapy
|
US9616090B2
(en)
|
2014-07-30 |
2017-04-11 |
Sangamo Biosciences, Inc. |
Gene correction of SCID-related genes in hematopoietic stem and progenitor cells
|
HUE055583T2
(hu)
|
2014-09-16 |
2021-12-28 |
Sangamo Therapeutics Inc |
Eljárások és készítmények nukleáz által közvetített genommódosításhoz és -javításhoz hematopoetikus õssejtekben
|
EA201790675A1
(ru)
|
2014-09-23 |
2017-08-31 |
Эгдженетикс, Инк. |
Материалы и способы для выведения животных с короткой шерстью
|
RU2706965C2
(ru)
|
2014-10-15 |
2019-11-21 |
Регенерон Фармасьютикалз, Инк. |
Способы и композиции для получения или поддержания плюрипотентных клеток
|
JP6153180B2
(ja)
|
2014-11-04 |
2017-06-28 |
国立大学法人神戸大学 |
脱塩基反応により標的化したdna配列に特異的に変異を導入する、ゲノム配列の改変方法、並びにそれに用いる分子複合体
|
AU2015346422A1
(en)
|
2014-11-12 |
2017-05-25 |
Recombinetics, Inc. |
Heterozygous modifications of tumor suppressor genes and swine model of neurofibromatosis type 1
|
MX2017006408A
(es)
|
2014-11-17 |
2018-03-23 |
Adicet Bio Inc |
Linfocitos t gamma delta modificados geneticamente.
|
PT3221457T
(pt)
|
2014-11-21 |
2019-06-27 |
Regeneron Pharma |
Métodos e composições para modificação genética visada através da utilização de arn guia emparelhados
|
PL3689140T3
(pl)
|
2014-11-24 |
2022-09-05 |
Regeneron Pharmaceuticals, Inc. |
Zwierzęta inne niż ludzie eksprymujące humanizowany kompleks CD3
|
CN104450785A
(zh)
*
|
2014-12-08 |
2015-03-25 |
复旦大学 |
使用编码靶向核酸内切酶附着体载体的基因组编辑方法及试剂盒
|
US10889834B2
(en)
|
2014-12-15 |
2021-01-12 |
Sangamo Therapeutics, Inc. |
Methods and compositions for enhancing targeted transgene integration
|
JP6840077B2
(ja)
|
2014-12-19 |
2021-03-10 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッドRegeneron Pharmaceuticals, Inc. |
単一ステップの複数標的化を通じた標的化された遺伝子修飾のための方法及び組成物
|
US20180002379A1
(en)
|
2015-01-21 |
2018-01-04 |
Sangamo Therapeutics, Inc. |
Methods and compositions for identification of highly specific nucleases
|
US20180094243A1
(en)
|
2015-04-03 |
2018-04-05 |
Dana-Farber Cancer Institute, Inc. |
Composition and methods of genome editing of b-cells
|
EP3289104B1
(de)
|
2015-04-29 |
2020-11-04 |
New York University |
Verfahren zur behandlung von hochwertigen gliomen
|
US10179918B2
(en)
|
2015-05-07 |
2019-01-15 |
Sangamo Therapeutics, Inc. |
Methods and compositions for increasing transgene activity
|
BR112017024115A2
(pt)
|
2015-05-12 |
2018-08-07 |
Sangamo Therapeutics Inc |
regulação de expressão genética mediada por nuclease
|
US9957501B2
(en)
|
2015-06-18 |
2018-05-01 |
Sangamo Therapeutics, Inc. |
Nuclease-mediated regulation of gene expression
|
US11612149B2
(en)
|
2015-07-10 |
2023-03-28 |
Chugai Seiyaku Kabushiki Kaisha |
Non-human animal having human CD3 gene substituted for endogenous CD3 gene
|
AU2016291778B2
(en)
|
2015-07-13 |
2021-05-06 |
Sangamo Therapeutics, Inc. |
Delivery methods and compositions for nuclease-mediated genome engineering
|
BR112018004636A2
(pt)
|
2015-09-09 |
2018-10-30 |
National University Corporation Kobe University |
método para modificação de um sítio alvejado em um dna de fita dupla de uma bactéria gram-positiva, complexo de enzima modificadora de ácido nucleico, e, ácido nucleico
|
JP6853257B2
(ja)
|
2015-09-23 |
2021-03-31 |
サンガモ セラピューティクス, インコーポレイテッド |
Httリプレッサー及びその使用
|
EP3673732A3
(de)
|
2015-10-27 |
2020-07-29 |
Recombinetics, Inc. |
Engineering von humanisierten car t-zellen und -plättchen durch genetische ergänzung
|
CN108473976B
(zh)
|
2015-10-28 |
2022-07-19 |
桑格摩生物治疗股份有限公司 |
肝特异性构建体、因子viii表达盒及其使用方法
|
PT3368673T
(pt)
|
2015-10-29 |
2020-08-27 |
Amyris Inc |
Composições e métodos para a produção de mirceno
|
WO2017079428A1
(en)
|
2015-11-04 |
2017-05-11 |
President And Fellows Of Harvard College |
Site specific germline modification
|
WO2017091512A1
(en)
|
2015-11-23 |
2017-06-01 |
Sangamo Biosciences, Inc. |
Methods and compositions for engineering immunity
|
KR102061438B1
(ko)
|
2015-11-27 |
2019-12-31 |
고쿠리츠다이가쿠호진 고베다이가쿠 |
표적화 dna 서열 중의 핵산 염기가 특이적으로 전환되어 있는 단자엽식물 게놈 서열을 전환시키는 방법, 및 그것에 사용되는 분자 복합체
|
WO2017106537A2
(en)
|
2015-12-18 |
2017-06-22 |
Sangamo Biosciences, Inc. |
Targeted disruption of the mhc cell receptor
|
CN108778297B
(zh)
|
2015-12-18 |
2024-02-09 |
桑格摩生物治疗股份有限公司 |
T细胞受体的靶向破坏
|
US20170202931A1
(en)
|
2016-01-15 |
2017-07-20 |
Sangamo Therapeutics, Inc. |
Methods and compositions for the treatment of neurologic disease
|
CN109069568B
(zh)
|
2016-02-02 |
2023-07-07 |
桑格摩生物治疗股份有限公司 |
用于连接dna结合结构域和切割结构域的组合物
|
WO2017183724A1
(ja)
|
2016-04-21 |
2017-10-26 |
国立大学法人神戸大学 |
ゲノム配列改変技術における変異導入効率の向上方法、及びそれに用いる分子複合体
|
MX2018013864A
(es)
|
2016-05-12 |
2019-06-10 |
Adicet Bio Inc |
Métodos para la expansión selectiva de poblaciones de células t gama y composicicones de estas.
|
US11293021B1
(en)
|
2016-06-23 |
2022-04-05 |
Inscripta, Inc. |
Automated cell processing methods, modules, instruments, and systems
|
ES2938210T3
(es)
|
2016-07-13 |
2023-04-05 |
Vertex Pharma |
Métodos, composiciones y kits para aumentar la eficiencia de edición del genoma
|
ES2965134T3
(es)
|
2016-07-29 |
2024-04-11 |
Regeneron Pharma |
Ratones que contienen mutaciones que resultan en la expresión de fibrilina-1 truncada en C
|
US11193136B2
(en)
|
2016-08-09 |
2021-12-07 |
Vib Vzw |
Cellulose synthase inhibitors and mutant plants
|
US11774442B2
(en)
|
2016-08-15 |
2023-10-03 |
Enevolv, Inc. |
Molecule sensor systems
|
US11793180B2
(en)
*
|
2016-08-22 |
2023-10-24 |
Chugai Seiyaku Kabushiki Kaisha |
Gene-modified mouse expressing human GPC3 polypeptide
|
LT3504229T
(lt)
|
2016-08-24 |
2021-12-10 |
Sangamo Therapeutics, Inc. |
Genų raiškos reguliavimas, panaudojant rekombinantines nukleazes
|
WO2018039448A1
(en)
|
2016-08-24 |
2018-03-01 |
Sangamo Therapeutics, Inc. |
Engineered target specific nucleases
|
JP7256739B2
(ja)
|
2016-09-07 |
2023-04-12 |
サンガモ セラピューティクス, インコーポレイテッド |
肝臓遺伝子のモジュレーション
|
WO2018057790A1
(en)
|
2016-09-21 |
2018-03-29 |
Recombinetics, Inc. |
Animal models for cardiomyopathy
|
DK3523326T3
(da)
|
2016-10-04 |
2020-08-03 |
Prec Biosciences Inc |
Samstimulerende domæner til anvendelse i genetisk modificerede celler
|
GB201617559D0
(en)
|
2016-10-17 |
2016-11-30 |
University Court Of The University Of Edinburgh The |
Swine comprising modified cd163 and associated methods
|
KR20190060829A
(ko)
|
2016-10-20 |
2019-06-03 |
상가모 테라퓨틱스, 인코포레이티드 |
파브리병의 치료를 위한 방법 및 조성물
|
WO2018081775A1
(en)
|
2016-10-31 |
2018-05-03 |
Sangamo Therapeutics, Inc. |
Gene correction of scid-related genes in hematopoietic stem and progenitor cells
|
US20180142249A1
(en)
*
|
2016-11-21 |
2018-05-24 |
Dow Agrosciences Llc |
Site specific integration of a transgne using intra-genomic recombination via a non-homologous end joining repair pathway
|
WO2018106782A1
(en)
|
2016-12-08 |
2018-06-14 |
Case Western Reserve University |
Methods and compositions for enhancing functional myelin production
|
BR112019014841A2
(pt)
|
2017-01-23 |
2020-04-28 |
Regeneron Pharma |
rna guia, uso do rna guia, rna antissentido, sirna ou shrna, uso do rna antissentido, do sirna ou do shrna, ácido nucleico isolado, vetor, composição, célula, e, métodos para modificar um gene hsd17b13 em uma célula, para diminuir a expressão de um gene hsd17b13 em uma célula, para modificar uma célula e para tratar um indivíduo que não é portador da variante de hsd17b13
|
SG11201908782XA
(en)
|
2017-03-22 |
2019-10-30 |
Univ Kobe Nat Univ Corp |
Method for converting nucleic acid sequence of cell specifically converting nucleic acid base of targeted dna using cell endogenous dna modifying enzyme, and molecular complex used therein
|
JP7297676B2
(ja)
|
2017-04-28 |
2023-06-26 |
アクイタス セラピューティクス インコーポレイテッド |
新規なカルボニル脂質、および核酸を送達するための脂質ナノ粒子製剤
|
RU2019139045A
(ru)
|
2017-05-03 |
2021-06-03 |
Сангамо Терапьютикс, Инк. |
Способы и композиции для модификации гена регулятора трансмембранной проводимости при кистозном фиброзе (cftr)
|
CA3062698A1
(en)
|
2017-05-08 |
2018-11-15 |
Precision Biosciences, Inc. |
Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof
|
EP3409104A1
(de)
|
2017-05-31 |
2018-12-05 |
Vilmorin et Cie |
Tomatenpflanze, die gegen tomatengelbblattkräuselvirus, pulverförmigen mehltau und nematoden beständig ist
|
EP3409106A1
(de)
|
2017-06-01 |
2018-12-05 |
Vilmorin et Cie |
Toleranz in pflanzen von solanum lycopersicum gegenüber dem tobamovirus tomato brown rugose fruit virus (tbrfv)
|
WO2020249996A1
(en)
|
2019-06-14 |
2020-12-17 |
Vilmorin & Cie |
Resistance in plants of solanum lycopersicum to the tobamovirus tomato brown rugose fruit virus
|
AU2018282072A1
(en)
|
2017-06-05 |
2020-01-16 |
Regeneron Pharmaceuticals, Inc. |
B4GALT1 variants and uses thereof
|
US11512287B2
(en)
|
2017-06-16 |
2022-11-29 |
Sangamo Therapeutics, Inc. |
Targeted disruption of T cell and/or HLA receptors
|
US9982279B1
(en)
|
2017-06-23 |
2018-05-29 |
Inscripta, Inc. |
Nucleic acid-guided nucleases
|
US10011849B1
(en)
|
2017-06-23 |
2018-07-03 |
Inscripta, Inc. |
Nucleic acid-guided nucleases
|
JP2020529834A
(ja)
|
2017-06-30 |
2020-10-15 |
プレシジョン バイオサイエンシズ,インク. |
T細胞受容体アルファ遺伝子の改変されたイントロンを含む遺伝子改変t細胞
|
US20190002874A1
(en)
|
2017-06-30 |
2019-01-03 |
Inscripta, Inc. |
Cell libraries created using rationally designed nucleic acids
|
JP7402521B2
(ja)
|
2017-07-11 |
2023-12-21 |
コンパス セラピューティクス リミテッド ライアビリティ カンパニー |
ヒトcd137に結合するアゴニスト性抗体およびその使用
|
EP3585160A2
(de)
|
2017-07-31 |
2020-01-01 |
Regeneron Pharmaceuticals, Inc. |
Nichtmenschliche crispr-reporter-tiere und verwendungen davon
|
SG11201912235PA
(en)
|
2017-07-31 |
2020-01-30 |
Regeneron Pharma |
Cas-transgenic mouse embryonic stem cells and mice and uses thereof
|
BR112019027673A2
(pt)
|
2017-07-31 |
2020-09-15 |
Regeneron Pharmaceuticals, Inc. |
animal não humano, e, métodos para testar a recombinação induzida por crispr/cas e para otimizar a capacidade de crispr/cas
|
US20190045761A1
(en)
|
2017-08-11 |
2019-02-14 |
Recombinetics, Inc. |
Inducible disease models methods of making them and use in tissue complementation
|
US10738327B2
(en)
|
2017-08-28 |
2020-08-11 |
Inscripta, Inc. |
Electroporation cuvettes for automation
|
CN111511199A
(zh)
|
2017-08-29 |
2020-08-07 |
科沃施种子欧洲股份两合公司 |
改良蓝色糊粉及其他分离系统
|
EP3684389A4
(de)
|
2017-09-21 |
2021-06-16 |
Dana Farber Cancer Institute, Inc. |
Isolierung, konservierung, zusammensetzungen und verwendungen von extrakten aus justicia-pflanzen
|
ES2962277T3
(es)
|
2017-09-29 |
2024-03-18 |
Regeneron Pharma |
Roedores que comprenden un locus Ttr humanizado y métodos de uso
|
CN111372650A
(zh)
|
2017-09-30 |
2020-07-03 |
因思科瑞普特公司 |
流通式电穿孔仪器
|
EP4269560A3
(de)
|
2017-10-03 |
2024-01-17 |
Precision Biosciences, Inc. |
Modifizierte epidermale wachstumsfaktorrezeptorpeptide zur verwendung in genetisch modifizierten zellen
|
WO2019089753A2
(en)
|
2017-10-31 |
2019-05-09 |
Compass Therapeutics Llc |
Cd137 antibodies and pd-1 antagonists and uses thereof
|
EP3704238B1
(de)
|
2017-11-01 |
2024-01-03 |
Precision Biosciences, Inc. |
Gegen humane und canine faktor-viii-gene gerichtete manipulierte nukleasen als behandlung für hämophilie a
|
CN111565730A
(zh)
|
2017-11-09 |
2020-08-21 |
桑格摩生物治疗股份有限公司 |
细胞因子诱导型含sh2蛋白(cish)基因的遗传修饰
|
JP2021502816A
(ja)
|
2017-11-15 |
2021-02-04 |
アディセット バイオ, インコーポレイテッド |
δ3γδT細胞集団の選択的増殖方法及びその組成物
|
EP3713961A2
(de)
|
2017-11-20 |
2020-09-30 |
Compass Therapeutics LLC |
Cd137-antikörper und tumorantigenbindende antikörper sowie deren verwendung
|
CA3082922C
(en)
|
2017-11-22 |
2024-02-13 |
National University Corporation Kobe University |
Complex for genome editing having stability and few side-effects, and nucleic acid coding same
|
EP3740479A1
(de)
|
2018-01-17 |
2020-11-25 |
Vertex Pharmaceuticals Incorporated |
Dna-pk-inhibitoren
|
WO2019143677A1
(en)
|
2018-01-17 |
2019-07-25 |
Vertex Pharmaceuticals Incorporated |
Quinoxalinone compounds, compositions, methods, and kits for increasing genome editing efficiency
|
AU2019209293B2
(en)
|
2018-01-17 |
2023-07-27 |
Vertex Pharmaceuticals Incorporated |
DNA-PK inhibitors
|
WO2019157324A1
(en)
|
2018-02-08 |
2019-08-15 |
Sangamo Therapeutics, Inc. |
Engineered target specific nucleases
|
WO2019161133A1
(en)
|
2018-02-15 |
2019-08-22 |
Memorial Sloan Kettering Cancer Center |
Foxp3 targeting agent compositions and methods of use for adoptive cell therapy
|
CN111936617A
(zh)
|
2018-03-16 |
2020-11-13 |
益缪索夫特公司 |
经遗传工程化以分泌卵泡抑素的b细胞以及使用所述b细胞来治疗卵泡抑素相关的疾病、病况、病症及增强肌肉生长和力量的方法
|
CA3089331A1
(en)
|
2018-03-19 |
2019-09-26 |
Regeneron Pharmaceuticals, Inc. |
Transcription modulation in animals using crispr/cas systems
|
KR102287880B1
(ko)
|
2018-03-26 |
2021-08-09 |
고쿠리츠다이가쿠호진 고베다이가쿠 |
세포에서 이중 가닥 dna의 표적 부위를 변형시키기 위한 방법
|
US10435662B1
(en)
|
2018-03-29 |
2019-10-08 |
Inscripta, Inc. |
Automated control of cell growth rates for induction and transformation
|
KR20210020873A
(ko)
|
2018-04-05 |
2021-02-24 |
주노 쎄러퓨티크스 인코퍼레이티드 |
재조합 수용체를 발현하는 τ 세포, 관련 폴리뉴클레오티드 및 방법
|
US20210017249A1
(en)
|
2018-04-05 |
2021-01-21 |
Juno Therapeutics, Inc. |
Methods of producing cells expressing a recombinant receptor and related compositions
|
WO2019200004A1
(en)
|
2018-04-13 |
2019-10-17 |
Inscripta, Inc. |
Automated cell processing instruments comprising reagent cartridges
|
US11421007B2
(en)
|
2018-04-18 |
2022-08-23 |
Sangamo Therapeutics, Inc. |
Zinc finger protein compositions for modulation of huntingtin (Htt)
|
WO2019209926A1
(en)
|
2018-04-24 |
2019-10-31 |
Inscripta, Inc. |
Automated instrumentation for production of peptide libraries
|
US10526598B2
(en)
|
2018-04-24 |
2020-01-07 |
Inscripta, Inc. |
Methods for identifying T-cell receptor antigens
|
US10858761B2
(en)
|
2018-04-24 |
2020-12-08 |
Inscripta, Inc. |
Nucleic acid-guided editing of exogenous polynucleotides in heterologous cells
|
US11690921B2
(en)
|
2018-05-18 |
2023-07-04 |
Sangamo Therapeutics, Inc. |
Delivery of target specific nucleases
|
GB201809273D0
(en)
|
2018-06-06 |
2018-07-25 |
Vib Vzw |
Novel mutant plant cinnamoyl-coa reductase proteins
|
CA3108767A1
(en)
|
2018-06-30 |
2020-01-02 |
Inscripta, Inc. |
Instruments, modules, and methods for improved detection of edited sequences in live cells
|
US20210310039A1
(en)
|
2018-07-31 |
2021-10-07 |
The University Of Tokyo |
Membrane protein activity measurement method
|
CA3107268A1
(en)
|
2018-08-07 |
2020-02-13 |
Modalis Therapeutics Corporation |
Novel transcription activator
|
CN109097370A
(zh)
*
|
2018-08-08 |
2018-12-28 |
华南农业大学 |
一种调控茶树茸毛形成的方法
|
EP3607819A1
(de)
|
2018-08-10 |
2020-02-12 |
Vilmorin et Cie |
Resistenz gegen xanthomonas campestris pv. campestris (xcc) in blumenkohl
|
US11142740B2
(en)
|
2018-08-14 |
2021-10-12 |
Inscripta, Inc. |
Detection of nuclease edited sequences in automated modules and instruments
|
US10532324B1
(en)
|
2018-08-14 |
2020-01-14 |
Inscripta, Inc. |
Instruments, modules, and methods for improved detection of edited sequences in live cells
|
US11834686B2
(en)
|
2018-08-23 |
2023-12-05 |
Sangamo Therapeutics, Inc. |
Engineered target specific base editors
|
WO2020047282A1
(en)
|
2018-08-29 |
2020-03-05 |
University Of Copenhagen |
Lysosomal enzymes modified by cell based glycoengineering
|
CN112955540A
(zh)
|
2018-08-30 |
2021-06-11 |
因思科瑞普特公司 |
在自动化模块和仪器中对经核酸酶经编辑的序列的改进的检测
|
JP2022500052A
(ja)
|
2018-09-18 |
2022-01-04 |
サンガモ セラピューティクス, インコーポレイテッド |
プログラム細胞死1(pd1)特異的ヌクレアーゼ
|
EP3867372A1
(de)
*
|
2018-10-16 |
2021-08-25 |
Blueallele, LLC |
Verfahren zur gezielten insertion von dna in genen
|
US10604746B1
(en)
|
2018-10-22 |
2020-03-31 |
Inscripta, Inc. |
Engineered enzymes
|
US11214781B2
(en)
|
2018-10-22 |
2022-01-04 |
Inscripta, Inc. |
Engineered enzyme
|
MX2021005594A
(es)
|
2018-11-13 |
2021-10-22 |
Compass Therapeutics Llc |
Constructos multiespecificos de union contra moleculas de puntos de control y usos de los mismos.
|
WO2020112870A1
(en)
|
2018-11-28 |
2020-06-04 |
Forty Seven, Inc. |
Genetically modified hspcs resistant to ablation regime
|
JP2022510387A
(ja)
|
2018-12-03 |
2022-01-26 |
アディセット バイオ, インコーポレイテッド |
ガンマデルタt細胞集団の選択的生体内増殖方法及びその組成物
|
KR20200071198A
(ko)
|
2018-12-10 |
2020-06-19 |
네오이뮨텍, 인코퍼레이티드 |
Nrf2 발현 조절 기반 T 세포 항암면역치료법
|
GB201820109D0
(en)
|
2018-12-11 |
2019-01-23 |
Vib Vzw |
Plants with a lignin trait and udp-glycosyltransferase mutation
|
MX2021007400A
(es)
|
2018-12-20 |
2021-07-15 |
Regeneron Pharma |
Expansion de repeticiones mediada por nucleasas.
|
EP3898661A1
(de)
|
2018-12-21 |
2021-10-27 |
Precision BioSciences, Inc. |
Genetische modifikation des hydroxysäure-oxidase-1-gens zur behandlung von primärer hyperoxalurie
|
EP3908568A1
(de)
|
2019-01-11 |
2021-11-17 |
Acuitas Therapeutics, Inc. |
Lipide zur lipidnanopartikelfreisetzung von wirkstoffen
|
US11857641B2
(en)
|
2019-02-06 |
2024-01-02 |
Sangamo Therapeutics, Inc. |
Method for the treatment of mucopolysaccharidosis type I
|
AU2020247900A1
(en)
|
2019-03-25 |
2021-11-04 |
Inscripta, Inc. |
Simultaneous multiplex genome editing in yeast
|
US11001831B2
(en)
|
2019-03-25 |
2021-05-11 |
Inscripta, Inc. |
Simultaneous multiplex genome editing in yeast
|
EP3946384A1
(de)
|
2019-04-02 |
2022-02-09 |
Sangamo Therapeutics, Inc. |
Verfahren zur behandlung von beta-thalassämie
|
EP4332115A2
(de)
|
2019-04-03 |
2024-03-06 |
Precision Biosciences, Inc. |
Genetisch modifizierte immunzellen mit einer mikrorna-adaptierten shrna (shrnamir)
|
AU2020256225A1
(en)
|
2019-04-03 |
2021-09-02 |
Regeneron Pharmaceuticals, Inc. |
Methods and compositions for insertion of antibody coding sequences into a safe harbor locus
|
WO2020206139A1
(en)
|
2019-04-04 |
2020-10-08 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals comprising a humanized coagulation factor 12 locus
|
KR102487901B1
(ko)
|
2019-04-04 |
2023-01-12 |
리제너론 파마슈티칼스 인코포레이티드 |
표적화된 변형의 표적화 벡터로의 무흔적 도입을 위한 방법
|
CA3136265A1
(en)
|
2019-04-05 |
2020-10-08 |
Precision Biosciences, Inc. |
Methods of preparing populations of genetically-modified immune cells
|
WO2020204159A1
(ja)
|
2019-04-05 |
2020-10-08 |
国立大学法人大阪大学 |
ノックイン細胞の作製方法
|
SG11202111360YA
(en)
|
2019-05-01 |
2021-11-29 |
Juno Therapeutics Inc |
Cells expressing a recombinant receptor from a modified tgfbr2 locus, related polynucleotides and methods
|
AU2020265749A1
(en)
|
2019-05-01 |
2022-01-06 |
Juno Therapeutics, Inc. |
Cells expressing a chimeric receptor from a modified CD247 locus, related polynucleotides and methods
|
JP2022534867A
(ja)
|
2019-06-04 |
2022-08-04 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
ベータスリップ変異を有するヒト化ttr遺伝子座を含む非ヒト動物と使用方法
|
US10837021B1
(en)
|
2019-06-06 |
2020-11-17 |
Inscripta, Inc. |
Curing for recursive nucleic acid-guided cell editing
|
SG11202111256XA
(en)
|
2019-06-07 |
2021-11-29 |
Regeneron Pharma |
Non-human animals comprising a humanized albumin locus
|
KR20220024053A
(ko)
|
2019-06-14 |
2022-03-03 |
리제너론 파마슈티칼스 인코포레이티드 |
타우병증의 모델
|
WO2020254850A1
(en)
|
2019-06-21 |
2020-12-24 |
Vilmorin & Cie |
Improvement of quality and permanence of green color of peppers at maturity and over-maturity
|
US10920189B2
(en)
|
2019-06-21 |
2021-02-16 |
Inscripta, Inc. |
Genome-wide rationally-designed mutations leading to enhanced lysine production in E. coli
|
US10927385B2
(en)
|
2019-06-25 |
2021-02-23 |
Inscripta, Inc. |
Increased nucleic-acid guided cell editing in yeast
|
WO2021011936A2
(en)
|
2019-07-18 |
2021-01-21 |
University Of Rochester |
Cell-type selective immunoprotection of cells
|
EP4004216A1
(de)
|
2019-07-25 |
2022-06-01 |
Precision BioSciences, Inc. |
Zusammensetzungen und verfahren zum sequenziellen stapeln von nukleinsäuresequenzen in einen genomischen locus
|
WO2021019272A1
(en)
|
2019-07-31 |
2021-02-04 |
Vilmorin & Cie |
Tolerance to tolcndv in cucumber
|
WO2021035054A1
(en)
|
2019-08-20 |
2021-02-25 |
Precision Biosciences, Inc. |
Lymphodepletion dosing regimens for cellular immunotherapies
|
WO2021035170A1
(en)
|
2019-08-21 |
2021-02-25 |
Precision Biosciences, Inc. |
Compositions and methods for tcr reprogramming using fusion proteins
|
US20220411479A1
(en)
|
2019-10-30 |
2022-12-29 |
Precision Biosciences, Inc. |
Cd20 chimeric antigen receptors and methods of use for immunotherapy
|
JP2022553573A
(ja)
|
2019-11-08 |
2022-12-23 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
X連鎖性若年網膜分離療法のためのcrisprおよびaav戦略
|
WO2021094805A1
(en)
|
2019-11-14 |
2021-05-20 |
Vilmorin & Cie |
Resistance to acidovorax valerianellae in corn salad
|
US11203762B2
(en)
|
2019-11-19 |
2021-12-21 |
Inscripta, Inc. |
Methods for increasing observed editing in bacteria
|
WO2021108363A1
(en)
|
2019-11-25 |
2021-06-03 |
Regeneron Pharmaceuticals, Inc. |
Crispr/cas-mediated upregulation of humanized ttr allele
|
CA3160096A1
(en)
|
2019-12-06 |
2021-06-10 |
Bruce J. Mccreedy Jr. |
Methods for cancer immunotherapy
|
CN114787347A
(zh)
|
2019-12-10 |
2022-07-22 |
因思科瑞普特公司 |
新颖的mad核酸酶
|
US10704033B1
(en)
|
2019-12-13 |
2020-07-07 |
Inscripta, Inc. |
Nucleic acid-guided nucleases
|
JP2023507566A
(ja)
|
2019-12-18 |
2023-02-24 |
インスクリプタ, インコーポレイテッド |
核酸誘導ヌクレアーゼ編集済み細胞のin vivo検出のためのカスケード/dCas3相補性アッセイ
|
US10689669B1
(en)
|
2020-01-11 |
2020-06-23 |
Inscripta, Inc. |
Automated multi-module cell processing methods, instruments, and systems
|
CA3157061A1
(en)
|
2020-01-27 |
2021-08-05 |
Christian SILTANEN |
Electroporation modules and instrumentation
|
WO2021158915A1
(en)
|
2020-02-06 |
2021-08-12 |
Precision Biosciences, Inc. |
Recombinant adeno-associated virus compositions and methods for producing and using the same
|
JP2023515671A
(ja)
|
2020-03-04 |
2023-04-13 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
免疫療法に対する腫瘍細胞の感作のための方法及び組成物
|
US20230102342A1
(en)
|
2020-03-23 |
2023-03-30 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals comprising a humanized ttr locus comprising a v30m mutation and methods of use
|
CN115697044A
(zh)
|
2020-03-31 |
2023-02-03 |
艾洛生物系统有限公司 |
西瓜和其他葫芦科中内源罗汉果苷途径基因的调控
|
US20210332388A1
(en)
|
2020-04-24 |
2021-10-28 |
Inscripta, Inc. |
Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells
|
JP2023525513A
(ja)
|
2020-05-06 |
2023-06-16 |
セレクティス ソシエテ アノニム |
細胞ゲノムにおける外因性配列の標的化挿入のための方法
|
WO2021224416A1
(en)
|
2020-05-06 |
2021-11-11 |
Cellectis S.A. |
Methods to genetically modify cells for delivery of therapeutic proteins
|
US20230183664A1
(en)
|
2020-05-11 |
2023-06-15 |
Precision Biosciences, Inc. |
Self-limiting viral vectors encoding nucleases
|
EP4150057A2
(de)
|
2020-05-13 |
2023-03-22 |
Juno Therapeutics, Inc. |
Verfahren zur herstellung von donor-batch zellen, die einen rekombinanten rezeptor exprimieren
|
US11787841B2
(en)
|
2020-05-19 |
2023-10-17 |
Inscripta, Inc. |
Rationally-designed mutations to the thrA gene for enhanced lysine production in E. coli
|
WO2021245435A1
(en)
|
2020-06-03 |
2021-12-09 |
Vilmorin & Cie |
Melon plants resistant to scab disease, aphids and powdery mildew
|
EP4161252A1
(de)
|
2020-06-05 |
2023-04-12 |
Vilmorin & Cie |
Resistenz in pflanzen von solanum lycopersicum gegen tobrfv
|
KR20230042283A
(ko)
|
2020-06-26 |
2023-03-28 |
주노 테라퓨틱스 게엠베하 |
재조합 수용체를 조건부로 발현하는 조작된 t 세포, 관련된 폴리뉴클레오티드 및 방법
|
EP4192875A1
(de)
|
2020-08-10 |
2023-06-14 |
Precision BioSciences, Inc. |
Antikörper und fragmente spezifisch für b-zellreifungsantigen und verwendungen davon
|
WO2022050413A1
(ja)
|
2020-09-04 |
2022-03-10 |
国立大学法人神戸大学 |
小型化シチジンデアミナーゼを含む二本鎖dnaの改変用複合体
|
US11299731B1
(en)
|
2020-09-15 |
2022-04-12 |
Inscripta, Inc. |
CRISPR editing to embed nucleic acid landing pads into genomes of live cells
|
CN116322313A
(zh)
|
2020-10-02 |
2023-06-23 |
维尔莫林公司 |
保质期延长的甜瓜
|
US20230365995A1
(en)
|
2020-10-07 |
2023-11-16 |
Precision Biosciences, Inc. |
Lipid nanoparticle compositions
|
MX2023004761A
(es)
|
2020-10-23 |
2023-07-17 |
Elo Life Systems Inc |
Metodos para producir plantas de vainilla con mejor sabor y produccion agronomica.
|
KR20230090367A
(ko)
|
2020-11-04 |
2023-06-21 |
주노 쎄러퓨티크스 인코퍼레이티드 |
변형된 불변 cd3 이뮤노글로불린 슈퍼패밀리 쇄 유전자좌로부터 키메라 수용체를 발현하는 세포 및 관련 폴리뉴클레오티드 및 방법
|
EP4242237A1
(de)
|
2020-11-06 |
2023-09-13 |
Editforce, Inc. |
Foki-nukleasedomänenvariante
|
US11512297B2
(en)
|
2020-11-09 |
2022-11-29 |
Inscripta, Inc. |
Affinity tag for recombination protein recruitment
|
US20240049668A1
(en)
|
2020-12-03 |
2024-02-15 |
Vilmorin & Cie |
Tomato plants resistant to tobrfv, tmv, tomv and tommv and corresponding resistance genes
|
EP4271802A1
(de)
|
2021-01-04 |
2023-11-08 |
Inscripta, Inc. |
Mad-nukleasen
|
EP4274890A1
(de)
|
2021-01-07 |
2023-11-15 |
Inscripta, Inc. |
Mad-nukleasen
|
EP4284823A1
(de)
|
2021-01-28 |
2023-12-06 |
Precision BioSciences, Inc. |
Modulation der tgf-beta-signalisierung in genetisch modifizierten eukaryotischen zellen
|
US11884924B2
(en)
|
2021-02-16 |
2024-01-30 |
Inscripta, Inc. |
Dual strand nucleic acid-guided nickase editing
|
EP4313122A1
(de)
|
2021-03-23 |
2024-02-07 |
Iovance Biotherapeutics, Inc. |
Cish-geneditierung von tumorinfiltrierenden lymphozyten und verwendungen davon in der immuntherapie
|
WO2022208489A1
(en)
|
2021-04-02 |
2022-10-06 |
Vilmorin & Cie |
Semi-determinate or determinate growth habit trait in cucurbita
|
WO2022226316A1
(en)
|
2021-04-22 |
2022-10-27 |
Precision Biosciences, Inc. |
Compositions and methods for generating male sterile plants
|
IL282597B
(en)
*
|
2021-04-22 |
2022-08-01 |
B G Negev Technologies And Applications Ltd At Ben Gurion Univ |
Birds for creating female offspring and methods for creating them
|
EP4337769A1
(de)
|
2021-05-10 |
2024-03-20 |
SQZ Biotechnologies Company |
Verfahren zur abgabe von genomeditierungsmolekülen an den zellkern oder cytosol einer zelle und verwendungen davon
|
WO2022251644A1
(en)
|
2021-05-28 |
2022-12-01 |
Lyell Immunopharma, Inc. |
Nr4a3-deficient immune cells and uses thereof
|
WO2022256437A1
(en)
|
2021-06-02 |
2022-12-08 |
Lyell Immunopharma, Inc. |
Nr4a3-deficient immune cells and uses thereof
|
IL310564A
(en)
|
2021-08-06 |
2024-03-01 |
Vilmorin & Cie |
Resistance to Leveillula Taurica in pepper plant
|
JP7125727B1
(ja)
|
2021-09-07 |
2022-08-25 |
国立大学法人千葉大学 |
核酸配列改変用組成物および核酸配列の標的部位を改変する方法
|
US20230242922A1
(en)
|
2021-09-13 |
2023-08-03 |
Life Technologies Corporation |
Gene editing tools
|
WO2023064924A1
(en)
|
2021-10-14 |
2023-04-20 |
Codiak Biosciences, Inc. |
Modified producer cells for extracellular vesicle production
|
WO2023064872A1
(en)
|
2021-10-14 |
2023-04-20 |
Precision Biosciences, Inc. |
Combinations of anti-bcma car t cells and gamma secretase inhibitors
|
CA3235185A1
(en)
|
2021-10-19 |
2023-04-27 |
Cassandra GORSUCH |
Gene editing methods for treating alpha-1 antitrypsin (aat) deficiency
|
WO2023076897A1
(en)
|
2021-10-25 |
2023-05-04 |
Fios Therapeutics, Llc |
Viable galactosyltransferase knock-out sheep and related methods
|
AU2022379633A1
(en)
|
2021-10-27 |
2024-04-11 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for expressing factor ix for hemophilia b therapy
|
WO2023081756A1
(en)
|
2021-11-03 |
2023-05-11 |
The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone |
Precise genome editing using retrons
|
WO2023081923A1
(en)
|
2021-11-08 |
2023-05-11 |
Frequency Therapeutics, Inc. |
Platelet-derived growth factor receptor (pdgfr) alpha inhibitors and uses thereof
|
WO2023081900A1
(en)
|
2021-11-08 |
2023-05-11 |
Juno Therapeutics, Inc. |
Engineered t cells expressing a recombinant t cell receptor (tcr) and related systems and methods
|
WO2023091910A1
(en)
|
2021-11-16 |
2023-05-25 |
Precision Biosciences, Inc. |
Methods for cancer immunotherapy
|
GB202117314D0
(en)
|
2021-11-30 |
2022-01-12 |
Clarke David John |
Cyclic nucleic acid fragmentation
|
WO2023108047A1
(en)
|
2021-12-08 |
2023-06-15 |
Regeneron Pharmaceuticals, Inc. |
Mutant myocilin disease model and uses thereof
|
GB202118058D0
(en)
|
2021-12-14 |
2022-01-26 |
Univ Warwick |
Methods to increase yields in crops
|
WO2023129974A1
(en)
|
2021-12-29 |
2023-07-06 |
Bristol-Myers Squibb Company |
Generation of landing pad cell lines
|
WO2023131616A1
(en)
|
2022-01-05 |
2023-07-13 |
Vib Vzw |
Means and methods to increase abiotic stress tolerance in plants
|
WO2023131637A1
(en)
|
2022-01-06 |
2023-07-13 |
Vib Vzw |
Improved silage grasses
|
WO2023141602A2
(en)
|
2022-01-21 |
2023-07-27 |
Renagade Therapeutics Management Inc. |
Engineered retrons and methods of use
|
WO2023144199A1
(en)
|
2022-01-26 |
2023-08-03 |
Vib Vzw |
Plants having reduced levels of bitter taste metabolites
|
US20230338477A1
(en)
|
2022-02-02 |
2023-10-26 |
Regeneron Pharmaceuticals, Inc. |
Anti-tfr:gaa and anti-cd63:gaa insertion for treatment of pompe disease
|
WO2023150798A1
(en)
|
2022-02-07 |
2023-08-10 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for defining optimal treatment timeframes in lysosomal disease
|
US20230257432A1
(en)
|
2022-02-11 |
2023-08-17 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for screening 4r tau targeting agents
|
WO2023178297A1
(en)
|
2022-03-18 |
2023-09-21 |
Obsidian Therapeutics, Inc. |
Compact drug responsive domains for regulation of function/abundance and delivery of polypeptide payloads
|
EP4256950A1
(de)
|
2022-04-06 |
2023-10-11 |
Vilmorin et Cie |
Toleranz gegenüber cgmmv in gurken
|
WO2023220603A1
(en)
|
2022-05-09 |
2023-11-16 |
Regeneron Pharmaceuticals, Inc. |
Vectors and methods for in vivo antibody production
|
WO2023225665A1
(en)
|
2022-05-19 |
2023-11-23 |
Lyell Immunopharma, Inc. |
Polynucleotides targeting nr4a3 and uses thereof
|
GB2621813A
(en)
|
2022-06-30 |
2024-02-28 |
Univ Newcastle |
Preventing disease recurrence in Mitochondrial replacement therapy
|
WO2024026474A1
(en)
|
2022-07-29 |
2024-02-01 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for transferrin receptor (tfr)-mediated delivery to the brain and muscle
|
WO2024031053A1
(en)
|
2022-08-05 |
2024-02-08 |
Regeneron Pharmaceuticals, Inc. |
Aggregation-resistant variants of tdp-43
|
WO2024044723A1
(en)
|
2022-08-25 |
2024-02-29 |
Renagade Therapeutics Management Inc. |
Engineered retrons and methods of use
|
WO2024064958A1
(en)
|
2022-09-23 |
2024-03-28 |
Lyell Immunopharma, Inc. |
Methods for culturing nr4a-deficient cells
|
WO2024064952A1
(en)
|
2022-09-23 |
2024-03-28 |
Lyell Immunopharma, Inc. |
Methods for culturing nr4a-deficient cells overexpressing c-jun
|
WO2024073606A1
(en)
|
2022-09-28 |
2024-04-04 |
Regeneron Pharmaceuticals, Inc. |
Antibody resistant modified receptors to enhance cell-based therapies
|
WO2024077174A1
(en)
|
2022-10-05 |
2024-04-11 |
Lyell Immunopharma, Inc. |
Methods for culturing nr4a-deficient cells
|